Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6334605rdf:typepubmed:Citationlld:pubmed
pubmed-article:6334605lifeskim:mentionsumls-concept:C0034721lld:lifeskim
pubmed-article:6334605lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:6334605lifeskim:mentionsumls-concept:C1882726lld:lifeskim
pubmed-article:6334605lifeskim:mentionsumls-concept:C0677626lld:lifeskim
pubmed-article:6334605lifeskim:mentionsumls-concept:C0003250lld:lifeskim
pubmed-article:6334605lifeskim:mentionsumls-concept:C0010762lld:lifeskim
pubmed-article:6334605lifeskim:mentionsumls-concept:C0031412lld:lifeskim
pubmed-article:6334605lifeskim:mentionsumls-concept:C0017262lld:lifeskim
pubmed-article:6334605lifeskim:mentionsumls-concept:C0205369lld:lifeskim
pubmed-article:6334605lifeskim:mentionsumls-concept:C0205263lld:lifeskim
pubmed-article:6334605lifeskim:mentionsumls-concept:C0936012lld:lifeskim
pubmed-article:6334605lifeskim:mentionsumls-concept:C2911684lld:lifeskim
pubmed-article:6334605lifeskim:mentionsumls-concept:C0000431lld:lifeskim
pubmed-article:6334605lifeskim:mentionsumls-concept:C0185117lld:lifeskim
pubmed-article:6334605pubmed:issue3lld:pubmed
pubmed-article:6334605pubmed:dateCreated1985-2-8lld:pubmed
pubmed-article:6334605pubmed:abstractTextWe have studied the expression of aldrin eposidase (AE), 7-ethoxycoumarin-O-deethylase (ECDE), and aryl hydrocarbon (benzo[a]pyrene) hydroxylase (AHH) in nine differentiated or dedifferentiated cell lines derived from H4IIEC3 rat hepatoma cells. The nature of the cytochromes P-450 mediating AE, ECDE and AHH activities was analysed using monoclonal antibodies (MAb) made to the major 3-methylcholanthrene-induced cytochrome P-450 (MAb-MC) or phenobarbital-induced cytochrome P-450 (MAb-PB) from rat liver. The cells were treated with 5 microM dexamethasone for 30 h to increase the levels of the monoxygenase activities. (a) The six differentiated cell lines examined (Faza967, Fao, HF1-4, 2sFou, C2Rev7, and H4IIEC3/G-) contained MAb-PB-sensitive AE comprising 30-75% of the total AE activity. In most of these cell lines MAb-PB also markedly inhibited ECDE; however, the antibody had a considerably weaker effect on AHH. (b) MAb-PB-sensitive AHH, ECDE and AE activities were also observed in untreated and phenobarbital-treated cells. (c) MAb-MC inhibited AHH and ECDE in the two dedifferentiated lines HF1 and H5 by 50-80%. The antibody also inhibited AHH activities in the poorly differentiated line H4IIEC3/T and in the majority of the differentiated lines by 40-65%. MAb-MC-sensitive AHH was found in Fao cells after treatment with benz[a]anthracene but induced AHH in H4IIEC3/T, H4IIEC3/G-, and 2sFou cells 20-30-fold and in Faza967 and Fao cells 3-5-fold. Benz[a]anthracene remained without effect on AHH activity in C2Rev7 cells. The results show that the hepatoma cells examined express to various degrees phenobarbital-inducible cytochrome P-450 and/or 3-methylcholanthrene-inducible cytochrome P-450. These cell lines are versatile tools for studying the regulation of monooxygenase activities and analysing their role in the activation and inactivation of xenobiotics such as carcinogens, drugs and pesticides.lld:pubmed
pubmed-article:6334605pubmed:languageenglld:pubmed
pubmed-article:6334605pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6334605pubmed:citationSubsetIMlld:pubmed
pubmed-article:6334605pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6334605pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6334605pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6334605pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6334605pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6334605pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6334605pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6334605pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6334605pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6334605pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6334605pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6334605pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6334605pubmed:statusMEDLINElld:pubmed
pubmed-article:6334605pubmed:monthDeclld:pubmed
pubmed-article:6334605pubmed:issn0014-2956lld:pubmed
pubmed-article:6334605pubmed:authorpubmed-author:GelboinH VHVlld:pubmed
pubmed-article:6334605pubmed:authorpubmed-author:WiebelF JFJlld:pubmed
pubmed-article:6334605pubmed:authorpubmed-author:ParkS SSSlld:pubmed
pubmed-article:6334605pubmed:authorpubmed-author:KiefenBBlld:pubmed
pubmed-article:6334605pubmed:issnTypePrintlld:pubmed
pubmed-article:6334605pubmed:day17lld:pubmed
pubmed-article:6334605pubmed:volume145lld:pubmed
pubmed-article:6334605pubmed:ownerNLMlld:pubmed
pubmed-article:6334605pubmed:authorsCompleteYlld:pubmed
pubmed-article:6334605pubmed:pagination455-62lld:pubmed
pubmed-article:6334605pubmed:dateRevised2007-7-23lld:pubmed
pubmed-article:6334605pubmed:meshHeadingpubmed-meshheading:6334605-...lld:pubmed
pubmed-article:6334605pubmed:meshHeadingpubmed-meshheading:6334605-...lld:pubmed
pubmed-article:6334605pubmed:meshHeadingpubmed-meshheading:6334605-...lld:pubmed
pubmed-article:6334605pubmed:meshHeadingpubmed-meshheading:6334605-...lld:pubmed
pubmed-article:6334605pubmed:meshHeadingpubmed-meshheading:6334605-...lld:pubmed
pubmed-article:6334605pubmed:meshHeadingpubmed-meshheading:6334605-...lld:pubmed
pubmed-article:6334605pubmed:meshHeadingpubmed-meshheading:6334605-...lld:pubmed
pubmed-article:6334605pubmed:meshHeadingpubmed-meshheading:6334605-...lld:pubmed
pubmed-article:6334605pubmed:meshHeadingpubmed-meshheading:6334605-...lld:pubmed
pubmed-article:6334605pubmed:meshHeadingpubmed-meshheading:6334605-...lld:pubmed
pubmed-article:6334605pubmed:meshHeadingpubmed-meshheading:6334605-...lld:pubmed
pubmed-article:6334605pubmed:meshHeadingpubmed-meshheading:6334605-...lld:pubmed
pubmed-article:6334605pubmed:meshHeadingpubmed-meshheading:6334605-...lld:pubmed
pubmed-article:6334605pubmed:meshHeadingpubmed-meshheading:6334605-...lld:pubmed
pubmed-article:6334605pubmed:meshHeadingpubmed-meshheading:6334605-...lld:pubmed
pubmed-article:6334605pubmed:meshHeadingpubmed-meshheading:6334605-...lld:pubmed
pubmed-article:6334605pubmed:meshHeadingpubmed-meshheading:6334605-...lld:pubmed
pubmed-article:6334605pubmed:meshHeadingpubmed-meshheading:6334605-...lld:pubmed
pubmed-article:6334605pubmed:meshHeadingpubmed-meshheading:6334605-...lld:pubmed
pubmed-article:6334605pubmed:year1984lld:pubmed
pubmed-article:6334605pubmed:articleTitleExpression of cytochromes P-450 in rat hepatoma cells. Analysis by monoclonal antibodies specific for cytochromes P-450 from rat liver induced by 3-methylcholanthrene or phenobarbital.lld:pubmed
pubmed-article:6334605pubmed:publicationTypeJournal Articlelld:pubmed